Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points

Maura Rossi; Alessio Gambino; Marco Cabras; Manuela Alessio; Vittorio Fusco

doi:10.1007/s00520-021-06100-4

Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points

Maura Rossi(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Alessio Gambino(University of Turin), Marco Cabras(University of Turin), Manuela Alessio(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Vittorio Fusco(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo)

Supportive Care in Cancer

February 25, 2021

10.1007/s00520-021-06100-4

Cited by 7

Abstract

Related Papers

No related papers found

Powered by citation graph analysis